Annual accounts
Micro Entity accounts
31/12/2026Filing deadline
- Next accounts made up to
- 31/03/2026
- Last accounts made up to
- 31/03/2025
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Appointment of Mrs Stephanie Anne Beer as a director on 2026-06-01
Appointment of Miss Janette Elizabeth Mannell as a secretary on 2026-02-23
Confirmation statement made on 2025-12-02 with no updates
Registered office address changed from 10 Coldbath Square London EC1R 5HL to 15 Stoneleigh Avenue Brighton BN1 8NP on 2026-01-12
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Micro Entity accounts
31/12/2026Filing deadline
Confirms the registry record is up to date
16/12/2026Filing deadline
The latest figures POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
2024: £215.63K
Total Assets
2024: £219.27K
Total Liabilities
2024: £3.65K
Employees
2024: 3
Of the 3 measures with an earlier filing to compare against, 2 rose and 1 fell. Net assets moved furthest, up 3.07% on 2024. See the full financial analysis for POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK.
The full financial record
Four ways through POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 3 | 0 |
| 2024 | 3 | -2 |
| 2023 | 5 | +2 |
| 2022 | 3 | +1 |
| 2021 | 2 | – |
Reported employee count increased from 2 in 2021 to 3 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 06/12/2023–Present | 0 | |
| Director | 13/06/2018–30/07/2020 | 11 | |
| Director | 30/11/2015–07/07/2022 | 7 | |
| Director | 02/12/2008–10/06/2011 | 0 | |
| Director | 07/10/2009–23/04/2010 | 0 | |
| Director | 02/12/2008–10/06/2011 | 0 | |
| Director | 02/12/2008–22/10/2009 | 1 | |
| Director | 08/06/2013–30/11/2015 | 0 | |
| Director | 07/10/2009–31/12/2013 | 0 | |
| Director | 08/09/2018–13/02/2024 | 0 | |
| Director | 02/12/2008–06/09/2025 | 0 | |
| Director | 07/10/2009–28/02/2010 | 0 | |
| Director | 01/02/2017–Present | 1 | |
| Director | 30/11/2015–11/04/2018 | 0 | |
| Director | 09/06/2011–06/06/2013 | 0 | |
| Director | 30/11/2015–09/09/2023 | 0 | |
| Director | 02/12/2008–10/06/2011 | 0 | |
| Director | 29/06/2022–Present | 0 | |
| Director | 21/06/2023–Present | 0 | |
| Director | 11/04/2018–06/09/2025 | 6 | |
| Director | 30/11/2015–09/09/2023 | 10 | |
| Director | 06/12/2023–Present | 1 | |
| Director | 01/06/2026–Present | 2 | |
| Director | 30/09/2020–Present | 89 | |
| Director | 09/06/2011–07/02/2018 | 0 | |
| Director | 23/04/2010–15/06/2016 | 0 | |
| Director | 04/02/2020–08/02/2022 | 2 | |
| Director | 02/12/2008–30/06/2010 | 0 | |
| Director | 09/06/2011–30/11/2015 | 2 | |
| Director | 02/12/2008–10/06/2011 | 1 | |
| Director | 08/06/2013–18/06/2015 | 0 | |
| Director | 30/11/2015–31/03/2017 | 1 | |
| Director | 11/09/2012–18/06/2015 | 0 | |
| Director | 06/09/2025–Present | 2 | |
| Director | 15/05/2026–Present | 0 | |
| Secretary | 23/02/2026–Present | 0 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 02/12/2016–Present | 0 |
Every document on the Companies House record, newest first.
Appointment of Mrs Stephanie Anne Beer as a director on 2026-06-01
Appointment of Miss Janette Elizabeth Mannell as a secretary on 2026-02-23
Confirmation statement made on 2025-12-02 with no updates
Registered office address changed from 10 Coldbath Square London EC1R 5HL to 15 Stoneleigh Avenue Brighton BN1 8NP on 2026-01-12
Micro company accounts made up to 2025-03-31
Appointment of Ms Margaret Fiona Bassendine as a director on 2025-09-06
Termination of appointment of Humphrey Julian Francis Hodgson as a director on 2025-09-06
Termination of appointment of Wendy Jane Morrison as a director on 2025-09-06
Termination of appointment of Sara Nicole Muller as a director on 2024-02-13
Confirmation statement made on 2024-12-02 with no updates
Micro company accounts made up to 2024-03-31
Register inspection address has been changed from 56 Manor Road London N16 5BN England to 21 Minety Road Swindon Wiltshire SN2 5PQ
Showing 12 of 24 filings
See when the next accounts and confirmation statement are due
1,541 UK companies are similar to POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK, sharing the same company status (Active), the same industry sector and activity group (Other service activities n.e.c. goods- and services-producing activities of households for own use) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
Suite 4000 43 Bedford Street, London WC2E 9HA
61 Station Road, Erdington, Birmingham B23 6UE
10 Great Colman Street, Ipswich IP4 2AD
7 Bramdean Drive, Havant PO9 4RP
22 Creake Road, Sculthorpe, Fakenham NR21 9NG
A short description of the company, written from its Companies House record.
POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK is a private limited company by guarantee without share capital, use of "limited" exemption registered in the United Kingdom, based in 15 Stoneleigh Avenue, Brighton BN1 8NP. Companies House classifies its business as Other service activities n.e.c. goods- and services-producing activities of households for own use. It has been on the register for 17 years 10 months.
The register currently records it as active. Its 2025 accounts report net assets of £222.25K and 3 employees.
Answered from this company's own registry record and filed figures.
Companies House records POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK under one registered business activity: Other service activities n.e.c. goods- and services-producing activities of households for own use (96.09 - SIC 2007).
POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS UK is recorded as active on the Companies House register, and has been on it since 02/12/2008.
The most recent accounts Okredo holds cover 2025 and report net assets of £222.25K, total assets of £224.15K and total liabilities of £1.90K.
The most recent document on the record is dated 02/06/2026: Appointment of Mrs Stephanie Anne Beer as a director on 2026-06-01, 4 months ago.
On the current registry record, accounts are due by 31/12/2026 and the next confirmation statement is due by 16/12/2026.
Companies House lists 36 officers (10 currently in post) and 1 person with significant control.